Home
ETON
ETON News

Latest Eton Pharmaceuticals Inc. (ETON) News on September 18, 2025

MT Newswires

3 months ago

Eton Pharmaceuticals to Be Added to Russell 2000 and 3000 Indexes

Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes

GlobeNewswire

3 months ago

Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes

Insiders Back These 3 High Growth Companies

Simply Wall St.

3 months ago

Insiders Back These 3 High Growth Companies

MT Newswires

3 months ago

Eton Pharmaceuticals Insider Sold Shares Worth $504,318, According to a Recent SEC Filing

Argus Research

3 months ago

Daily – Vickers Top Buyers & Sellers for 06/06/2025

Eton Pharmaceuticals (ETON) Upgraded to Buy: Here's Why

Zacks

4 months ago

Eton Pharmaceuticals (ETON) Upgraded to Buy: Here's Why

Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks

4 months ago

Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why

MT Newswires

4 months ago

Sector Update: Health Care Stocks Edge Higher Pre-Bell Thursday

MT Newswires

4 months ago

Sector Update: Health Care

FDA approves Eton’s application for hydrocortisone oral solution

Pharmaceutical Technology

4 months ago

FDA approves Eton’s application for hydrocortisone oral solution

Eton Pharmaceuticals, Inc. (ETON) Launches Game-Changer for Adrenal Insufficiency

Insider Monkey

4 months ago

Eton Pharmaceuticals, Inc. (ETON) Launches Game-Changer for Adrenal Insufficiency

MT Newswires

4 months ago

Eton Pharmaceuticals' Khindivi Gets FDA Approval for Pediatric Adrenocortical Insufficiency Treatment

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution

GlobeNewswire

4 months ago

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution

individual investors who own 43% along with institutions invested in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) saw increase in their holdings value last week

Simply Wall St.

4 months ago

individual investors who own 43% along with institutions invested in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) saw increase in their holdings value last week

Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

GlobeNewswire

4 months ago

Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

Thomson Reuters StreetEvents

4 months ago

Q1 2025 Eton Pharmaceuticals Inc Earnings Call

Eton Pharmaceuticals Inc (ETON) Q1 2025 Earnings Call Highlights: Revenue Soars 117% Amid ...

GuruFocus.com

4 months ago

Eton Pharmaceuticals Inc (ETON) Q1 2025 Earnings Call Highlights: Revenue Soars 117% Amid ...

Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates

Zacks

4 months ago

Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates

MT Newswires

4 months ago

Eton Pharmaceuticals Q1 Non-GAAP EPS, Revenue Increase

Eton Pharmaceuticals Reports First Quarter 2025 Financial Results

GlobeNewswire

4 months ago

Eton Pharmaceuticals Reports First Quarter 2025 Financial Results

Eton Pharmaceuticals Inc (ETON) Q1 2025 Earnings Report Preview: What To Expect

GuruFocus.com

4 months ago

Eton Pharmaceuticals Inc (ETON) Q1 2025 Earnings Report Preview: What To Expect

Earnings Preview: Merus N.V. (MRUS) Q1 Earnings Expected to Decline

Zacks

4 months ago

Earnings Preview: Merus N.V. (MRUS) Q1 Earnings Expected to Decline

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

GlobeNewswire

5 months ago

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release

Zacks

5 months ago

Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release

MT Newswires

5 months ago

Eton Pharmaceuticals Submits NDA to FDA for ET-600 to Treat Central Diabetes Insipidus

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)

GlobeNewswire

5 months ago

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Has Found A Path To Profitability

Simply Wall St.

5 months ago

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Has Found A Path To Profitability

MT Newswires

6 months ago

Eton Pharmaceuticals Agrees to License International Rights for Increlex to Esteve Pharmaceuticals

Eton Pharmaceuticals Out-Licenses International Rights to Increlex®

GlobeNewswire

6 months ago

Eton Pharmaceuticals Out-Licenses International Rights to Increlex®

Eton Pharmaceuticals Inc (ETON) Q4 2024 Earnings Report Preview: What To Expect

GuruFocus.com

6 months ago

Eton Pharmaceuticals Inc (ETON) Q4 2024 Earnings Report Preview: What To Expect

Eton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

6 months ago

Eton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates

Zacks

6 months ago

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

GlobeNewswire

6 months ago

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

MT Newswires

6 months ago

Eton's Diabetes Drug Candidate Passes Bioequivalence Study

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

GlobeNewswire

6 months ago

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

Is 89BIO (ETNB) Stock Outpacing Its Medical Peers This Year?

Zacks

6 months ago

Is 89BIO (ETNB) Stock Outpacing Its Medical Peers This Year?

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025

GlobeNewswire

6 months ago

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025

MT Newswires

7 months ago

Eton Pharmaceuticals Launches Galzin Capsules for Wilson Disease Treatment

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules

GlobeNewswire

7 months ago

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules

Intellia Therapeutics (NTLA) Stock Jumps 6.5%: Will It Continue to Soar?

Zacks

7 months ago

Intellia Therapeutics (NTLA) Stock Jumps 6.5%: Will It Continue to Soar?

Eton secures US patent for diabetes insipidus treatment

Pharmaceutical Technology

7 months ago

Eton secures US patent for diabetes insipidus treatment

MT Newswires

7 months ago

Eton Pharmaceuticals Says US Patent Granted for ET-600 Formulation

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600

GlobeNewswire

7 months ago

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600

MT Newswires

7 months ago

Eton Pharmaceuticals Says ET-400 FDA Decision Delayed to May

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400

GlobeNewswire

7 months ago

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400

New Strong Buy Stocks for January 28th

Zacks

8 months ago

New Strong Buy Stocks for January 28th

Eton Pharmaceuticals price target raised to $23 from $18 at Craig-Hallum

TipRanks

8 months ago

Eton Pharmaceuticals price target raised to $23 from $18 at Craig-Hallum

Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength?

Zacks

8 months ago

Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength?

Eton Pharmaceuticals, Inc. (ETON): Analysts Recommend This 52-Week High Stocks Now

Insider Monkey

8 months ago

Eton Pharmaceuticals, Inc. (ETON): Analysts Recommend This 52-Week High Stocks Now

MT Newswires

8 months ago

B. Riley Initiates Eton Pharmaceuticals With Buy Rating, $21 Price Target

Investing in Eton Pharmaceuticals (NASDAQ:ETON) three years ago would have delivered you a 177% gain

Simply Wall St.

8 months ago

Investing in Eton Pharmaceuticals (NASDAQ:ETON) three years ago would have delivered you a 177% gain

MT Newswires

8 months ago

Eton Pharmaceuticals Acquires Galzin to Expand Rare Disease Treatment Offerings

Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®

GlobeNewswire

8 months ago

Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®

MT Newswires

9 months ago

Eton Pharmaceuticals Acquires Increlex From Ipsen; Shares Rise

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)

GlobeNewswire

9 months ago

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)

Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial

GlobeNewswire

9 months ago

Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial

Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) top owners are retail investors with 58% stake, while 26% is held by institutions

Simply Wall St.

9 months ago

Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) top owners are retail investors with 58% stake, while 26% is held by institutions

Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer

GlobeNewswire

9 months ago

Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer

Eton acquires US rights to neonatal diabetes treatment from AMMTeK

Pharmaceutical Technology

10 months ago

Eton acquires US rights to neonatal diabetes treatment from AMMTeK

Eton Pharmaceuticals acquires U.S. rights to Amglidia from AMMTeK

TipRanks

10 months ago

Eton Pharmaceuticals acquires U.S. rights to Amglidia from AMMTeK

MT Newswires

10 months ago

Eton Pharmaceuticals Acquires US Rights to Neonatal Diabetes Drug Amglidia

Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)

GlobeNewswire

10 months ago

Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)

Eton Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

10 months ago

Eton Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

Thomson Reuters StreetEvents

10 months ago

Q3 2024 Eton Pharmaceuticals Inc Earnings Call

Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...

GuruFocus.com

10 months ago

Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results

GlobeNewswire

10 months ago

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results

What To Expect From Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings

GuruFocus.com

10 months ago

What To Expect From Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings

Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)

GlobeNewswire

10 months ago

Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)

Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

GlobeNewswire

10 months ago

Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Eton Pharmaceuticals price target raised to $15 from $10 at Craig-Hallum

TipRanks

a year ago

Eton Pharmaceuticals price target raised to $15 from $10 at Craig-Hallum

Opaleye Management Inc. Reduces Stake in Eton Pharmaceuticals Inc.

GuruFocus.com

a year ago

Opaleye Management Inc. Reduces Stake in Eton Pharmaceuticals Inc.

ACCESSWIRE

a year ago

SWK Holdings Provides Portfolio Update

Analysts Expect Breakeven For Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Before Long

Simply Wall St.

a year ago

Analysts Expect Breakeven For Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Before Long

Opaleye Management Inc. Bolsters Portfolio with Strategic Acquisition of Eton Pharmaceuticals Shares

GuruFocus.com

a year ago

Opaleye Management Inc. Bolsters Portfolio with Strategic Acquisition of Eton Pharmaceuticals Shares

MT Newswires

a year ago

Eton Pharmaceuticals to Acquire Increlex From Ipsen

Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen

GlobeNewswire

a year ago

Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen

GuruFocus.com

a year ago

Opaleye Management Inc. Increases Stake in Eton Pharmaceuticals Inc.

Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

a year ago

Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Eton Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

a year ago

Eton Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results

GlobeNewswire

a year ago

Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results

Shareholders in Eton Pharmaceuticals (NASDAQ:ETON) are in the red if they invested five years ago

Simply Wall St.

a year ago

Shareholders in Eton Pharmaceuticals (NASDAQ:ETON) are in the red if they invested five years ago

Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

GlobeNewswire

a year ago

Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

ACCESSWIRE

a year ago

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

MT Newswires

a year ago

Eton Pharmaceuticals Shares Surge After FDA Accepts ET-400 New Drug Application For Review

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

GlobeNewswire

a year ago

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

Are Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Simply Wall St.

a year ago

Are Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Eton Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations

Simply Wall St.

a year ago

Eton Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations

Thomson Reuters StreetEvents

a year ago

Q1 2024 Eton Pharmaceuticals Inc Earnings Call

Eton Pharmaceuticals Reports First Quarter 2024 Financial Results

GlobeNewswire

a year ago

Eton Pharmaceuticals Reports First Quarter 2024 Financial Results

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) On The Verge Of Breaking Even

Simply Wall St.

a year ago

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) On The Verge Of Breaking Even

Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference

GlobeNewswire

a year ago

Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference

MT Newswires

a year ago

Eton Pharmaceuticals Submits New Drug Application to FDA For ET-400

Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

GlobeNewswire

a year ago

Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

GlobeNewswire

a year ago

Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria

GlobeNewswire

a year ago

Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Eton Pharmaceuticals Inc Earnings Call

Eton Pharmaceuticals Inc (ETON) Reports Robust Sales Growth and Pipeline Progress in Q4 and ...

GuruFocus.com

2 years ago

Eton Pharmaceuticals Inc (ETON) Reports Robust Sales Growth and Pipeline Progress in Q4 and ...

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates

Zacks

2 years ago

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates

Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

2 years ago

Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

Share on Social Networks: